Lauren P. Silvernail, CFO, CBO & Secretary at Revance Therapeutics, Inc. (RVNC), sold 10,000 shares at $26.83 ($268K) on 2017-11-07, disclosed to the SEC on 2017-11-09.
Open-market sale of $268k RVNC by CFO, CBO & Secretary. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| EOLS | SELL | 2022-03-10 | $198K | — | Filing → |
| EOLS | SELL | 2021-08-12 | $320K | — | Filing → |
| EOLS | SELL | 2021-01-26 | $20K | — | Filing → |